PMID: 20643037Jul 21, 2010Paper

Neurovascular intervention in the acute phase of cerebral infarction

Neurología : publicación oficial de la Sociedad Española de Neurología
A Cruz CulebrasJ Masjuan

Abstract

Endovascular therapies in acute ischaemic stroke may offer benefits to patients that are not eligible for standard use of intravenous tissue activator plasminogen (iv t-PA) or when this is not effective. Our aim is to present the initial experience in with endovascular techniques in the Community of Madrid. We present data from our registry of acute ischaemic strokes treated with endovascular re-perfusion therapies in five University Hospitals in Madrid (Spain) during the period 2005-2009. We recorded demographic data, vascular risk factors, risk severity with the NIHSS (National Institute of Health Stroke Scale), endovascular techniques, complications and mortality rates. Functional outcome and neurological disability at 90 days was defined by the modified Rankin scale (mRs). A total of 41 patients were treated with endovascular therapies. Mean age was 58.6 ± 19.9, and 56.1% were males. Of those 22 patients had an anterior circulation stroke and 19 had a posterior circulation stroke. Baseline NIHSS score was: median, 17 [range, 2-34]; 7 patients had previously received iv t-PA. The following endovascular techniques were performed: mechanical disruption (26 patients), intra-arterial infusion of t-PA (26 patients), angioplasty a...Continue Reading

References

Dec 1, 1988·Stroke; a Journal of Cerebral Circulation·R Bonita, R Beaglehole
Nov 1, 1994·Stroke; a Journal of Cerebral Circulation·P LydenJ Marler
Dec 7, 2002·Stroke; a Journal of Cerebral Circulation·Rejane C LisboaMark J Alberts
Mar 16, 2004·Stroke; a Journal of Cerebral Circulation·UNKNOWN IMS Study Investigators
Oct 30, 2004·Stroke; a Journal of Cerebral Circulation·Y Pierre GobinJeffrey L Saver
Aug 5, 2006·Stroke; a Journal of Cerebral Circulation·Stephen M Davis, Geoffrey A Donnan
Feb 10, 2007·Stroke; a Journal of Cerebral Circulation·Maher SaqqurUNKNOWN CLOTBUST Investigators
Jun 15, 2007·Neurology·Pitchaiah Mandava, Thomas A Kent
Feb 25, 2009·International Journal of Stroke : Official Journal of the International Stroke Society·Blanca Fuentes, Exuperio Díez-Tejedor
Nov 17, 2009·Medicina intensiva·J MasjuanUNKNOWN Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología

❮ Previous
Next ❯

Citations

Jan 9, 2013·International Journal of Stroke : Official Journal of the International Stroke Society·R SanyalC Roffe
May 15, 2013·Neurología : publicación oficial de la Sociedad Española de Neurología·M Alonso de LeciñanaUNKNOWN Comité ad hoc del Foro de Ictus de la Asociación Madrileña de Neurología

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.